Larson Financial Group’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $304K | Buy |
2,400
+494
| +26% | +$62.5K | 0.01% | 563 |
|
|
2025
Q1 | $244K | Buy |
1,906
+153
| +9% | +$19.6K | 0.01% | 581 |
|
|
2024
Q4 | $232K | Buy |
1,753
+102
| +6% | +$13.5K | 0.01% | 531 |
|
|
2024
Q3 | $240K | Buy |
1,651
+60
| +4% | +$8.73K | 0.01% | 520 |
|
|
2024
Q2 | $218K | Buy |
1,591
+6
| +0.4% | +$823 | 0.01% | 439 |
|
|
2024
Q1 | $217K | Buy |
1,585
+153
| +11% | +$21K | 0.02% | 387 |
|
|
2023
Q4 | $194K | Buy |
1,432
+57
| +4% | +$7.74K | 0.02% | 365 |
|
|
2023
Q3 | $168K | Buy |
1,375
+200
| +17% | +$24.5K | 0.02% | 361 |
|
|
2023
Q2 | $149K | Buy |
1,175
+96
| +9% | +$12.2K | 0.01% | 366 |
|
|
2023
Q1 | $139K | Buy |
1,079
+5
| +0.5% | +$646 | 0.02% | 374 |
|
|
2022
Q4 | $141K | Sell |
1,074
-41
| -4% | -$5.38K | 0.02% | 354 |
|
|
2022
Q3 | $130K | Buy |
1,115
+1,000
| +870% | +$117K | 0.02% | 326 |
|
|
2022
Q2 | $14K | Hold |
115
| – | – | ﹤0.01% | 626 |
|
|
2022
Q1 | $15K | Sell |
115
-38
| -25% | -$4.96K | ﹤0.01% | 570 |
|
|
2021
Q4 | $23K | Hold |
153
| – | – | ﹤0.01% | 515 |
|
|
2021
Q3 | $25K | Hold |
153
| – | – | 0.01% | 422 |
|
|
2021
Q2 | $25K | Buy |
153
+38
| +33% | +$6.21K | 0.01% | 392 |
|
|
2021
Q1 | $17K | Hold |
115
| – | – | 0.01% | 441 |
|
|
2020
Q4 | $17K | Buy |
115
+70
| +156% | +$10.3K | 0.01% | 401 |
|
|
2020
Q3 | $6K | Hold |
45
| – | – | ﹤0.01% | 502 |
|
|
2020
Q2 | $6K | Hold |
45
| – | – | ﹤0.01% | 450 |
|
|
2020
Q1 | $5K | Hold |
45
| – | – | ﹤0.01% | 365 |
|
|
2019
Q4 | $5K | Hold |
45
| – | – | ﹤0.01% | 366 |
|
|
2019
Q3 | $4K | Hold |
45
| – | – | ﹤0.01% | 382 |
|
|
2019
Q2 | $5K | Hold |
45
| – | – | ﹤0.01% | 311 |
|
|
2019
Q1 | $5K | Hold |
45
| – | – | ﹤0.01% | 292 |
|
|
2018
Q4 | $4K | Buy |
+45
| New | +$4K | ﹤0.01% | 295 |
|